Purchase Order 75N98026P00331
Award Date 7/25/26
Potential Completion Date 7/25/27
Potential Value $85K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August...
- <p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>
- <p>The National Human Genome Research Institute awarded a $220,000 purchase order to Pacific Biosciences of California, Inc. on April 18, 2019 for a PacBio Sequel System 8M upgrade. Work is performed in Menlo Park, California, with an ultimate completion date of October 31, 2019. The order uses firm fixed-price pricing with no small business set-aside.</p>
- <p>The Food and Drug Administration awarded a purchase order to Pacific Biosciences of California, Inc. for $51,193.93 on August 23, 2023, for sequencing supplies. Place of performance is Menlo Park, California. The order was firm fixed price with no small business set-aside. Ultimate completion was scheduled for February 19, 2024. The procurement originated from a solicitation posted June 30, 2023 with a due date of July 10, 2023.</p>
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
- The National Human Genome Research Institute (NHGRI) has awarded a $198,082.98 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio Single Molecule Real-Time (SMRT) cells and sequencing reagents. This new award, announced on September 16, 2025, with an ultimate completion date of September 26, 2026, represents a direct procurement of specialized laboratory consumables essential for advanced genomic sequencing operations. The contract carries no set-aside...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- <p>The National Institute of Child Health and Human Development awarded a purchase order to Pacific Biosciences of California, Inc. for $35,000 on April 21, 2020, with a one-year service agreement for a sequencer, completing April 22, 2021. The order is firm fixed price with no small business set-aside. Performance occurs in Bethesda, Maryland. The originating solicitation was posted March 20, 2020 with a due date of March 30, 2020.</p>